Your browser doesn't support javascript.
loading
Avenaciolide Induces Apoptosis in Human Malignant Meningioma Cells through the Production of Reactive Oxygen Species.
Katsuzawa, Takumi; Kujirai, Kohei; Kamisuki, Shinji; Shinoda, Yo.
Afiliação
  • Katsuzawa T; Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Kujirai K; Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Kamisuki S; Center for Human and Animal Symbiosis Science, Azabu University.
  • Shinoda Y; Laboratory of Chemistry, School of Veterinary Medicine, Azabu University.
Biol Pharm Bull ; 45(4): 517-521, 2022.
Article em En | MEDLINE | ID: mdl-35370277
Malignant meningioma has a poor prognosis and there are currently no effective therapies. Avenaciolide is water-insoluble natural organic product produced by Aspergillus avenaceus G. Smith that can inhibit mitochondrial function. In the present study, we investigated the anti-cancer effects of avenaciolide in an isolated human malignant meningioma cell line, HKBMM. In addition, to assess the specificity of avenaciolide, its effects on normal human neonatal dermal fibroblast HDFn cells were also examined. Avenaciolide showed effective anti-cancer activity, and its cytotoxicity in HKBMM cells was greater than that in HDFn cells. The anti-cancer effects of avenaciolide were mediated by reactive oxygen species (ROS)-induced apoptosis, which may have been caused by mitochondrial disfunction. These results suggest that avenaciolide has potential as a therapeutic drug for malignant meningioma.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Meníngeas / Meningioma Limite: Humans / Newborn Idioma: En Revista: Biol Pharm Bull Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Meníngeas / Meningioma Limite: Humans / Newborn Idioma: En Revista: Biol Pharm Bull Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article